NSE filing, NSE: DHTL. Summary written from the filing by ALFA Finder's alert engine.
Docmode Health Technologies Limited: key numbers
- Share price
- ₹22.05
- Market cap
- ₹6.93 Cr
- Revenue (annual)
- ₹25.52 Cr
- Net profit (annual)
- ₹-0.13 Cr
- P/E (TTM)
- -51.4×Sector 34.1×
- Promoter holding
- 29.50%
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Docmode Health Technologies Limited
All →Docmode Health Technologies Other Announcement
Doctrack Solutions Limited submitted its Reconciliation of Share Capital Audit Report for the quarter ended September 30, 2026. The report confirms a total issued capital of 31,42,800 equity shares.
Docmode Health Technologies Capital Structure Change
Ramesh Kumar Jain and Ramesh Jain HUF net acquired 20,000 DHTL shares on the open market, raising PAC stake to 11.45%. This SAST Reg 29(2) disclosure reflects a minor stake increase.
Docmode Health Technologies Annual General Meeting
Doctrack Solutions Limited conducted its 9th Annual General Meeting on September 30, 2026. Shareholders considered the adoption of audited financial statements and approved related party transactions.
Docmode Health Technologies Annual General Meeting
Docmode Health Technologies Limited issued the notice for its Annual General Meeting scheduled for September 30, 2026. The agenda includes financial statement adoption and RPT approval.
Docmode Health Technologies H2 FY26 Results: Net Loss of ₹0.1 Cr, Loss Narrows
Docmode Health Technologies Limited reported revenue from operations of ₹7.7 Cr (-64.0% YoY) and a net loss of ₹0.1 Cr for H2 FY26.
- Key figure
- Net loss ₹0.1 Cr
Docmode Health Technologies Board Meeting Date
Doctrack Solutions Limited has rescheduled its board meeting to September 4, 2026. The board will consider and approve audited financial results for the half-year ended March 2026.
Other other announcement announcements
All →Setubandhan Infrastructure Other Announcement
RP informs exchanges that Setubandhan Infrastructure cannot file quarterly compliance documents due to depository fee non-payment. The company remains under CIRP with a pending NCLAT appeal.
Man Infraconstruction Other Announcement
Man Infraconstruction filed a Reg 32 quarterly statement confirming no deviation in use of preferential-warrant proceeds. No deviation or variation arose for the quarter ended September 30, 2026.
Black Buck Other Announcement
BlackBuck's ICRA monitoring agency report for Q1 FY27 confirms IPO proceeds utilization remains in line with stated objects. No deviation was observed in the quarter.
Raama Finance Other Announcement
Raama Finance appointed M/s. Kumar Gaurav & Co. as statutory auditor for three months effective October 29, 2026. The routine appointment carries no financial impact.
Teja Engineering Industries Other Announcement
Teja Engineering Industries filed a non-applicability certificate for Reg 27(2) Corporate Governance for Q1 FY27. As an NSE Emerge-listed SME, the company is exempt from this periodic disclosure.
Prism Medico and Pharmacy Other Announcement
Prism Medico and Pharmacy intimated BSE and MSEI that its corporate website is updated and functional per Regulation 46. This is a routine compliance undertaking with no financial impact.